Thomas J. Herzfeld Advisors, Inc. - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 41 filers reported holding ENZO BIOCHEM INC in Q3 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
Thomas J. Herzfeld Advisors, Inc. ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q4 2018$33,000
-36.5%
11,882
-5.9%
0.01%
-27.8%
Q3 2018$52,000
-21.2%
12,6290.0%0.02%
-25.0%
Q2 2018$66,000
+450.0%
12,629
+321.0%
0.02%
+242.9%
Q1 2014$12,000
+33.3%
3,0000.0%0.01%
+40.0%
Q4 2013$9,000
+12.5%
3,0000.0%0.01%0.0%
Q3 2013$8,000
+33.3%
3,0000.0%0.01%
+25.0%
Q2 2013$6,0003,0000.00%
Other shareholders
ENZO BIOCHEM INC shareholders Q3 2023
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,436,771$7,822,00010.43%
VIEX Capital Advisors, LLC 1,736,087$5,573,0008.96%
HARBERT FUND ADVISORS, INC. 5,175,913$16,615,0004.19%
AMH Equity Ltd 596,742$1,916,0002.66%
Potomac Capital Management, Inc. 208,000$668,0000.59%
Agate Pass Investment Management, LLC 24,292$78,0000.05%
RBF Capital, LLC 250,359$804,0000.05%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$82,0000.05%
Corsair Capital Management 58,657$188,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 319,500$1,026,0000.02%
View complete list of ENZO BIOCHEM INC shareholders